MedPath

Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery

Phase 3
Completed
Conditions
Postoperative Complications
Cataract
Interventions
Drug: Placebo
Registration Number
NCT00198445
Lead Sponsor
Bausch & Lomb Incorporated
Brief Summary

The primary objective of this study was to investigate the efficacy of bromfenac sodium ophthalmic solution 0.09% for treatment of post-operative ocular inflammation in subjects who undergo cataract extraction and intraocular lens implantation. The secondary objective was to investigate the safety and tolerability of the same.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
527
Inclusion Criteria
  • Cataract surgery
  • Summed ocular inflammation score (anterior chamber cell score plus flare score) of >/= 3, 24 hours after the cataract extraction
  • Agreed to avoid disallowed medications (meds) throughout the duration of the study
Exclusion Criteria
  • Use of or need for non-steroidal anti-inflammatory agents (NSAIDs), steroids, anticoagulants, or other specific meds prohibited by the protocol
  • Uncontrolled chronic ocular or systemic disease, active corneal pathology or scarring noted in either eye (except keratopathy, allowed in non-study eye)
  • Extraocular/intraocular inflammation in either eye
  • Clinically significant (WHO CTC Grade 1 or greater) liver function tests

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboVehicle of bromfenac
BromfenacBromfenacTopical bromfenac ophthalmic solution 0.1%
Primary Outcome Measures
NameTimeMethod
Ocular Inflammation ScoreVisit 4 (Day 15)

Cleared ocular inflammation in the study eye, defined as summed ocular inflammation score (SOIS) of 1 or less (anterior chamber cell score plus flare score, each measured on a 5-point scale) 0=none

Secondary Outcome Measures
NameTimeMethod
Mean Ocular Inflammation ScoreAt each Visit 2 (Day3), Visit 3 (Day 8), Visit 4 (Day 15), Visit 5 (Day 22)

Mean change from baseline in SOIS at each visit.

Trial Locations

Locations (39)

Eye Care of San Diego

🇺🇸

San Diego, California, United States

Cornea Consultants

🇺🇸

Boston, Massachusetts, United States

Ophthalmic Consultants of Long Island

🇺🇸

Rockville Centre, New York, United States

Scheie Eye Institute

🇺🇸

Philadelphia, Pennsylvania, United States

Houston Eye Associates

🇺🇸

Houston, Texas, United States

Harold A Helms, MD

🇺🇸

Birmingham, Alabama, United States

Dean A McGee Eye Institute

🇺🇸

Oklahoma City, Oklahoma, United States

David G Shulman, MD

🇺🇸

San Antonio, Texas, United States

Eye Care Arkansas, PA

🇺🇸

Little Rock, Arkansas, United States

Saltzer Medical Group, PA

🇺🇸

Nampa, Idaho, United States

Black Hills Regional Eye Institute

🇺🇸

Rapid City, South Dakota, United States

Middle Tennessee Eye Associates

🇺🇸

Cookeville, Tennessee, United States

UCI, Department of Ophthalmology

🇺🇸

Irvine, California, United States

Richard A Lewis, MD

🇺🇸

Sacramento, California, United States

Anesthetic Eye Care Institute

🇺🇸

Newport Beach, California, United States

Cohen Laser Vision Center

🇺🇸

Boca Raton, Florida, United States

Santa Clara Valley Medical Center

🇺🇸

San Jose, California, United States

E Randy Craven, MD

🇺🇸

Littleton, Colorado, United States

Brandon Cataract Center & Eye Clinic

🇺🇸

Brandon, Florida, United States

Jack Daubert, MD

🇺🇸

West Palm Beach, Florida, United States

Marvin E Greenberg, MD, PA

🇺🇸

Tamarac, Florida, United States

Advanced Eye Care, PC

🇺🇸

Fort Oglethorpe, Georgia, United States

Donald E Beahm, MD

🇺🇸

Great Bend, Kansas, United States

Cincinnati Eye Institute NKY

🇺🇸

Edgewood, Kentucky, United States

Arthur J Weinstein, MD

🇺🇸

Albuquerque, New Mexico, United States

Great Lakes Eye Care

🇺🇸

St. Joseph, Michigan, United States

Horizon Eye Care

🇺🇸

Charlotte, North Carolina, United States

The Eye Institute

🇺🇸

Tulsa, Oklahoma, United States

Ophthalmology Service, Brooke Army Medical Center

🇺🇸

Ft. Sam Houston, Texas, United States

Ophthalmology Visual Science

🇺🇸

Galveston, Texas, United States

Central Texas Eye Center

🇺🇸

San Marcos, Texas, United States

Virginia Eye Consultants

🇺🇸

Norfolk, Virginia, United States

The Eye Care Group

🇺🇸

New Haven, Connecticut, United States

Tulane University Health Sciences Center

🇺🇸

New Orleans, Louisiana, United States

Stevenson Medical Surgical Eye Center

🇺🇸

New Orleans, Louisiana, United States

Hunkeler Eye Institute

🇺🇸

Kansas City, Missouri, United States

Casey Eye Institute

🇺🇸

Portland, Oregon, United States

Eye Health Northwest

🇺🇸

Portland, Oregon, United States

Texan Eye Care PA

🇺🇸

Austin, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath